Merck's Strategic $10B Acquisition of Verona Pharma
Merck & Co. plans to acquire Verona Pharma for $10 billion, enhancing its respiratory treatment portfolio and preparing for future revenue shifts.
Browsing:
business news
Thursday, October 1, 2026
Est. MMXXVIContact
New York DailyThe Five Boroughs, Every Day